期刊
CURRENT OPINION IN ONCOLOGY
卷 16, 期 5, 页码 429-435出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001622-200409000-00003
关键词
Burkitt lymphoma; Burkitt-like lymphoma; L3 acute lymphoblastic leukemia
类别
Purpose of review Despite significant improvements in the treatment of Burkitt lymphoma, outcomes of adults are generally inferior to those of children. This review summarizes the most recent developments in the management of Burkitt lymphoma and leukemia in adults. Recent findings Current regimens have largely been derived from pediatric protocols. High complete remission rates are typically achieved, but relapse remains a problem. Recent trials have validated or built upon findings from older studies. Summary The adoption of aggressive, multiagent, short-course therapy has markedly improved outcomes, but relapse rates remain relatively high in poorer-risk cohorts. New approaches are particularly needed in older patients to improve survival rates while minimizing toxicities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据